Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunologic parameters in systemic sclerosis

M Bruns1, K Herrmann, U F Haustein

  • 1Department of Dermatology, University of Leipzig, Germany.

International Journal of Dermatology
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preoperative immunotherapy with atezolizumab and tiragolumab in patients with colorectal liver metastases-the PURPLE trial.

ESMO gastrointestinal oncology·2026
Same author

New targets of PET imaging for renal cancer.

Seminars in nuclear medicine·2025
Same author

GMP- compliant formulation and quality control of sodium [<sup>124</sup>I]iodide for oral applications.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2025
Same author

Final overall survival and safety analyses of the phase III PSMAfore trial of [<sup>177</sup>Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Fibroblast-directed PET imaging reveals a case of retroperitoneal fibrosis after immunotherapy for metastatic urothelial cancer of the upper tract.

Urology case reports·2025
Same author

[Importance of peptide receptor radionuclide therapy for the management of neuroendocrine tumours].

Radiologie (Heidelberg, Germany)·2025
Same journal

SENTINOLD and the Challenge of Meaningful Risk Prediction in Melanoma.

International journal of dermatology·2026
Same journal

The "Stamp-n-Tack" Technique: An Ink-Guided Precision Method for Anchoring Tissue After Releasing Facial Retaining Ligaments in Large Facial Flap Reconstruction.

International journal of dermatology·2026
Same journal

Counterfactual Dermatology With Generative Models.

International journal of dermatology·2026
Same journal

Correlation of Clinical and Histopathological Features With Anti-Desmoglein Antibody Profile in Pemphigus Patients.

International journal of dermatology·2026
Same journal

Paracetamol-Induced Generalized Bullous Fixed Drug Eruption With Positive Anti-BP230 Antibody and Confirmed With Oral Provocation Test in a Child: A Case Report From the Philippines.

International journal of dermatology·2026
Same journal

Clinicopathological Challenge: A Painful Violaceous Reticulated Patch.

International journal of dermatology·2026
See all related articles

Systemic sclerosis (SSc) involves immune system abnormalities, particularly activated T-helper lymphocytes and elevated autoantibodies. These changes may drive fibrosis by stimulating fibroblast matrix protein synthesis.

Area of Science:

  • Immunology
  • Rheumatology
  • Cell Biology

Background:

  • Immunologic abnormalities are implicated in systemic sclerosis (SSc).
  • Understanding these immune dysregulations is crucial for SSc research.

Purpose of the Study:

  • To investigate immune parameters in SSc.
  • To gain insights into the immunopathogenesis of systemic sclerosis.

Main Methods:

  • Studied autoantibodies (ANA, anti-Scl-70, ACA).
  • Analyzed lymphocyte subpopulations and activation markers (CD2+, CD25+, CD71+, HLA-DR Ia).
  • Measured serum levels of IL-2, soluble IL-2 receptor (sIL-2R), and IL-6, correlating with P III P; assessed IL-6 production by SSc fibroblasts.

Main Results:

Related Experiment Videos

  • Active SSc patients showed reduced CD2+ T-lymphocytes.
  • Increased expression of T-lymphocyte activation markers (CD25+, CD71+, HLA-DR Ia) was observed.
  • Elevated serum sIL-2R and IL-6 levels were found, but SSc fibroblasts did not overproduce IL-6 in vitro.

    • Conclusions:

    • Systemic sclerosis exhibits widespread immunologic alterations.
    • Activated T-helper (TH) lymphocytes, potentially due to reduced T-suppressor (TS) and NK cells, may drive B-cell autoantibody production.
    • TH cell cytokines likely stimulate fibroblast matrix synthesis, contributing to SSc fibrosis.